Medpace Holdings, Inc. Contract Liability (Deferred Revenue)
Medpace Holdings, Inc. (MEDP) had Contract Liability (Deferred Revenue) of $904.72 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-07-23
- 2026-06-30: Contract with Customer, Liability, Current $904.72M.
- 2026-03-31: Contract with Customer, Liability, Current $856.34M.
- 2025-12-31: Contract with Customer, Liability, Current $854.39M.
- 2025-09-30: Contract with Customer, Liability, Current $834.33M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $904.72M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $856.34M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $854.39M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $834.33M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $808.78M 10-Q · filed 2025-07-22 |
| 2025-03-31 | $718.72M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $710.59M 10-K · filed 2026-02-10 |
| 2024-09-30 | $670.94M 10-Q · filed 2024-10-22 |
| 2024-06-30 | $638.42M 10-Q · filed 2024-07-23 |
| 2024-03-31 | $616.70M 10-Q · filed 2024-04-23 |
| 2023-12-31 | $559.86M 10-K · filed 2025-02-11 |
| 2023-09-30 | $518.75M 10-Q · filed 2023-10-24 |
| 2023-06-30 | $490.56M 10-Q · filed 2023-07-25 |
| 2023-03-31 | $466.04M 10-Q · filed 2023-04-25 |
| 2022-12-31 | $462.73M 10-K · filed 2024-02-13 |
| 2022-09-30 | $417.93M 10-Q · filed 2022-10-25 |
| 2022-06-30 | $401.37M 10-Q · filed 2022-07-26 |
| 2022-03-31 | $367.22M 10-Q · filed 2022-04-26 |
| 2021-12-31 | $344.64M 10-K · filed 2023-02-14 |
| 2021-09-30 | $303.85M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $282.22M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $277.81M 10-Q · filed 2021-04-27 |
| 2020-12-31 | $255.66M 10-K · filed 2022-02-15 |
| 2020-09-30 | $202.61M 10-Q · filed 2020-10-27 |
| 2020-06-30 | $195.35M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $189.56M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $192.36M 10-K · filed 2021-02-16 |
| 2019-09-30 | $169.53M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $165.45M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $150.24M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $147.94M 10-K · filed 2020-02-25 |
| 2018-09-30 | $133.40M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $120.94M 10-Q · filed 2018-07-31 |
| 2017-12-31 | $73.76M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |